Literature DB >> 18241200

The intact CFTR protein mediates ATPase rather than adenylate kinase activity.

Mohabir Ramjeesingh1, Francisca Ugwu, Fiona L L Stratford, Ling-Jun Huan, Canhui Li, Christine E Bear.   

Abstract

The two NBDs (nucleotide-binding domains) of ABC (ATP-binding-cassette) proteins function in a complex to mediate ATPase activity and this activity has been linked to their regulated transport activity. A similar model has been proposed for CFTR (cystic fibrosis transmembrane conductance regulator), the chloride channel defective in cystic fibrosis, wherein ATP binding and hydrolysis regulate the channel gate. Recently, it was shown that the individual NBDs isolated from CFTR primarily mediate adenylate kinase activity, raising the possibility that this activity may also contribute to gating of the CFTR channel. However, this present study shows that whereas the isolated NBDs exhibit adenylate kinase activity, the full-length purified and reconstituted CFTR protein functions as an ATPase, arguing that the enzymatic activity of the NBDs is dependent on their molecular context and appropriate domain-domain assembly. As expected, the disease-causing mutant bearing a mutation in the ABC signature motif, CFTR-G551D, exhibited a markedly reduced ATPase activity. Furthermore, mutation of the putative catalytic base in CFTR caused a reduction in ATPase activity, with the CFTR-E1371Q mutant supporting a low level of residual activity. Neither of these mutants exhibited detectable adenylate kinase activity. Together, these findings support the concept that the molecular mechanism of action of CFTR is dependent on ATP binding and hydrolysis, and that the structure of prokaryotic ABC ATPases provide a useful template for understanding their mechanism of action.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18241200     DOI: 10.1042/BJ20071719

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  18 in total

1.  The H-loop in the second nucleotide-binding domain of the cystic fibrosis transmembrane conductance regulator is required for efficient chloride channel closing.

Authors:  Monika Kloch; Michał Milewski; Ewa Nurowska; Beata Dworakowska; Garry R Cutting; Krzysztof Dołowy
Journal:  Cell Physiol Biochem       Date:  2010-01-12

2.  Membrane protein stability can be compromised by detergent interactions with the extramembranous soluble domains.

Authors:  Zhengrong Yang; Chi Wang; Qingxian Zhou; Jianli An; Ellen Hildebrandt; Luba A Aleksandrov; John C Kappes; Lawrence J DeLucas; John R Riordan; Ina L Urbatsch; John F Hunt; Christie G Brouillette
Journal:  Protein Sci       Date:  2014-05-03       Impact factor: 6.725

3.  A mutation in CFTR modifies the effects of the adenylate kinase inhibitor Ap5A on channel gating.

Authors:  Qian Dong; Christoph O Randak; Michael J Welsh
Journal:  Biophys J       Date:  2008-09-19       Impact factor: 4.033

4.  Dynamic expression of adenylate kinase 2 in the hippocampus of pilocarpine model rats.

Authors:  Xi Peng; Liang Wang; Guojun Chen; Xuefeng Wang
Journal:  J Mol Neurosci       Date:  2012-01-14       Impact factor: 3.444

5.  Channel Gating Regulation by the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) First Cytosolic Loop.

Authors:  Annette Ehrhardt; W Joon Chung; Louise C Pyle; Wei Wang; Krzysztof Nowotarski; Cory M Mulvihill; Mohabir Ramjeesingh; Jeong Hong; Sadanandan E Velu; Hal A Lewis; Shane Atwell; Steve Aller; Christine E Bear; Gergely L Lukacs; Kevin L Kirk; Eric J Sorscher
Journal:  J Biol Chem       Date:  2015-12-01       Impact factor: 5.157

6.  Kinetics of the association/dissociation cycle of an ATP-binding cassette nucleotide-binding domain.

Authors:  Maria E Zoghbi; Kerry L Fuson; Roger B Sutton; Guillermo A Altenberg
Journal:  J Biol Chem       Date:  2011-12-09       Impact factor: 5.157

7.  Potentiation of disease-associated cystic fibrosis transmembrane conductance regulator mutants by hydrolyzable ATP analogs.

Authors:  Haruna Miki; Zhen Zhou; Min Li; Tzyh-Chang Hwang; Silvia G Bompadre
Journal:  J Biol Chem       Date:  2010-04-20       Impact factor: 5.157

Review 8.  Current insights into the role of PKA phosphorylation in CFTR channel activity and the pharmacological rescue of cystic fibrosis disease-causing mutants.

Authors:  Stephanie Chin; Maurita Hung; Christine E Bear
Journal:  Cell Mol Life Sci       Date:  2016-10-08       Impact factor: 9.261

9.  Vx-770 potentiates CFTR function by promoting decoupling between the gating cycle and ATP hydrolysis cycle.

Authors:  Kang-Yang Jih; Tzyh-Chang Hwang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-25       Impact factor: 11.205

10.  Cystic fibrosis transmembrane conductance regulator (CFTR) potentiator VX-770 (ivacaftor) opens the defective channel gate of mutant CFTR in a phosphorylation-dependent but ATP-independent manner.

Authors:  Paul D W Eckford; Canhui Li; Mohabir Ramjeesingh; Christine E Bear
Journal:  J Biol Chem       Date:  2012-08-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.